Reply to L. Yaghjyan et al
JNCI Cancer Spectr
.
2018 Nov 3;2(3):pky046.
doi: 10.1093/jncics/pky046.
eCollection 2018 Jul.
Authors
Ashish A Deshmukh
1
,
Shervin M Shirvani
2
,
Anna Likhacheva
2
,
Jagpreet Chhatwal
3
,
Elizabeth Y Chiao
4
,
Kalyani Sonawane
1
5
Affiliations
1
Department of Management Policy, and Community Health, The University of Texas Health Science Centre School of Public Health, Houston, TX (AAD, KS).
2
Department of Radiation Oncology, Banner MD Anderson Cancer Center, Gilbert, AZ (SMS, AL).
3
Massachusetts General Hospital Institute for Technology Assessment, Harvard Medical School, Boston, MA (JC).
4
Department of Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, TX (EYC).
5
Centre for Healthcare Data, The University of Texas Health Science Centre School of Public Health, Houston, TX (KS).
PMID:
31361277
PMCID:
PMC6649707
DOI:
10.1093/jncics/pky046
No abstract available